Biotech startup Loyal has raised $125M to launch their longevity drug for dogs in 2025.
This drug works by lowering insulin/IGF1.
They claim that it will extend dog lifespan by at least a year.
(I have yet to see any publications from them so far to back that claim up, but it’s a big deal if true.)
Reference on 2025 launch:
m.slashdot.orgLink to m.slashdot.orgm.slashdot.orgQuoted:
“U.S. biotech startup Loyal plans to launch a lifespan-extending drug for dogs in early 2025, potentially offering insights into human longevity. The San Francisco-based company has secured $125 million in funding for LOY-002, a beef-flavored daily pill designed to extend canine lifespans by at least one year. The drug works by targeting age-related metabolic changes and insulin regulation [IGF1], according to Loyal CEO Celine Halioua.”
Note that there are many ways to lower insulin and IGF1 naturally by diet and lifestyle. Two of the most effective are not eating refined starch/sugar, and avoiding excessive amounts of insulinogenic animal proteins.
the GuardianScientists explore longevity drugs for dogs that could also ‘extend human life’Researchers say drugs may be able to increase lifespan by extending health and thus shortening the rate of ageingtheguardian.com
#igf1HD #agingGD #longevityHD #dogsHD #refinedstarchHD #refinedsugarHD #proteinHD #animalproteinHD #insulinHD #loyalHD
